Literature DB >> 8524762

[Results of the treatment of patients with recurrence of pulmonary tuberculosis with different types of haptoglobin].

B A Eĭsaev.   

Abstract

Phenotyping of haptoglobin Hp has been performed in 74 patients with recurrent tuberculosis. In patients with recurrences homozygous variant of phenotype Hp 2-2 occurs more frequently, while heterozygous variant Hp 2-1 less frequently. In carriers of phenotype Hp 2-2 recurrent tuberculosis is found more frequently, runs more seriously, heals in the presence of destruction less actively. These reasons underlie high incidence of chronic forms. Subjects with Hp 2-2 (55.3%) need special attention in conduction of recurrence prophylaxis. In carriers of phenotype Hp 2-1 pulmonary tuberculosis relapses less frequently, runs less seriously, resists to treatment rarely.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524762

Source DB:  PubMed          Journal:  Probl Tuberk        ISSN: 0032-9533


  2 in total

1.  A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels.

Authors:  Philippe Froguel; Ndeye Coumba Ndiaye; Amélie Bonnefond; Nabila Bouatia-Naji; Aurélie Dechaume; Gérard Siest; Bernard Herbeth; Mario Falchi; Leonardo Bottolo; Rosa-Maria Guéant-Rodriguez; Cécile Lecoeur; Michel R Langlois; Yann Labrune; Aimo Ruokonen; Said El Shamieh; Maria G Stathopoulou; Anita Morandi; Claudio Maffeis; David Meyre; Joris R Delanghe; Peter Jacobson; Lars Sjöström; Lena M S Carlsson; Andrew Walley; Paul Elliott; Marjo-Riita Jarvelin; George V Dedoussis; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

2.  Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in Hungarian patients.

Authors:  Maria Papp; Peter Laszlo Lakatos; Karoly Palatka; Ildiko Foldi; Miklos Udvardy; Jolan Harsfalvi; Istvan Tornai; Zsuzsanna Vitalis; Tamas Dinya; Agota Kovacs; Tamas Molnar; Pal Demeter; Janos Papp; Laszlo Lakatos; Istvan Altorjay
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.